291 related articles for article (PubMed ID: 5700408)
1. Round table discussion. Effects of long-term use of antifertility agents.
Int J Fertil; 1968; 13(4):476-90. PubMed ID: 5700408
[No Abstract] [Full Text] [Related]
2. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices.
Ober WB
Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919
[No Abstract] [Full Text] [Related]
3. Estrogen use and endometrial cancer.
Greenblatt RB
N Engl J Med; 1979 Apr; 300(16):921-2. PubMed ID: 423940
[No Abstract] [Full Text] [Related]
4. Serious adverse effects of oral contraceptives and estrogens.
Med Lett Drugs Ther; 1976 Feb; 18(5):21-2. PubMed ID: 1256357
[No Abstract] [Full Text] [Related]
5. Methods of fertility regulation: advances in research and clinical experience. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1971; 473():3-48. PubMed ID: 4998878
[No Abstract] [Full Text] [Related]
6. Recent progress on systemic contraceptives.
Matsumoto S
Acta Obstet Gynaecol Jpn; 1970 Jul; 17(3):211-9. PubMed ID: 4917512
[No Abstract] [Full Text] [Related]
7. Antifertility agents.
Roland M
Int J Fertil; 1968; 13(4):354-65. PubMed ID: 5700393
[TBL] [Abstract][Full Text] [Related]
8. An internist's observations of patients on long-term contraception.
Cole SL
J Reprod Med; 1970 Oct; 5(4):175-8. PubMed ID: 5521940
[No Abstract] [Full Text] [Related]
9. Oral contraceptives and thromboembolism.
Med Lett Drugs Ther; 1972 Aug; 14(17):61-2. PubMed ID: 4567564
[No Abstract] [Full Text] [Related]
10. [Oral estro-progestational agents and the uterine cervix].
de Brux J
Pathol Eur; 1972; 7(3):283-7. PubMed ID: 4657185
[No Abstract] [Full Text] [Related]
11. Oral contraceptives: a review of certain metabolic effects and an examination of the question of safety.
Goldzieher JW
Fed Proc; 1970; 29(3):1220-7. PubMed ID: 4910271
[No Abstract] [Full Text] [Related]
12. Hypertension and oral contraception.
Smith RW
Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):50-5. PubMed ID: 5164822
[No Abstract] [Full Text] [Related]
13. Oral contraceptives and endometrial and cervical cancer.
Moghissi KS
J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
[No Abstract] [Full Text] [Related]
14. Contraceptive technology: current and prospective methods.
Segal SJ; Tietze C
Rep Popul Fam Plann; 1969 Oct; ():1-20. PubMed ID: 4938390
[No Abstract] [Full Text] [Related]
15. Evaluation of the contraceptive efficacy of Quingestanol acetate in daily microdose and post coitum.
Moggia A; Mischler T; Beauquis A; Zarate J; Torrado M; Ferrari F; Koremblit E
J Reprod Med; 1973 Apr; 10(4):186-92. PubMed ID: 4735194
[No Abstract] [Full Text] [Related]
16. [The pill and thromboembolism. 2. Pathogenesis and additional risk factors. Review of the literature].
Herzog C; Mall-Haefeli M
Ther Ggw; 1979 Nov; 118(11):1722-44. PubMed ID: 395715
[No Abstract] [Full Text] [Related]
17. Topical and systemic contraceptive agents.
Med Lett Drugs Ther; 1974 Apr; 16(9):37-40. PubMed ID: 4823321
[No Abstract] [Full Text] [Related]
18. Response to contraception.
Roland M
Major Probl Obstet Gynecol; 1973; 5():1-162. PubMed ID: 4781770
[No Abstract] [Full Text] [Related]
19. [Oral contraception and liver function].
Bergsjo P
Tidsskr Nor Laegeforen; 1973 Mar; 93(9):583-8. PubMed ID: 4759808
[No Abstract] [Full Text] [Related]
20. Oral contraceptive agents and the glucose tolerance problem.
Cohn RE
Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284
[No Abstract] [Full Text] [Related]
[Next] [New Search]